Market Cap (In USD)
6.05 Million
Revenue (In USD)
1.17 Million
Net Income (In USD)
-13.02 Million
Avg. Volume
39.19 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.044-0.101
- PE
- -
- EPS
- -
- Beta Value
- 1.136
- ISIN
- CA97111B4047
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. Chris Savile
- Employee Count
- -
- Website
- https://www.willowbio.com
- Ipo Date
- 2021-01-08
- Details
- Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.
More Stocks
-
293780AptaBio Therapeutics Inc.
293780
-
950160Kolon TissueGene, Inc.
950160
-
129260Intergis Co., Ltd
129260
-
JELLFJEOL Ltd.
JELLF
-
IBJHFIbstock plc
IBJHF
-
1313
-
CPA
-
RSE